How big is the Oman Diabetes Drugs And Devices Market?

The Oman Diabetes Drugs And Devices Market size is expected to reach USD 209.02 million in 2025 and grow at a CAGR of greater than 5% to reach USD 266.77 million by 2030. Read More

What is the current Oman Diabetes Drugs And Devices Market size?

In 2025, the Oman Diabetes Drugs And Devices Market size is expected to reach USD 209.02 million. Read More

Who are the key players in Oman Diabetes Drugs And Devices Market?

Medtronics, Roche, NovoNordisk, Sanofi and Omnipod are the major companies operating in the Oman Diabetes Drugs And Devices Market. Read More

What years does this Oman Diabetes Drugs And Devices Market cover, and what was the market size in 2024?

In 2024, the Oman Diabetes Drugs And Devices Market size was estimated at USD 198.57 million. The report covers the Oman Diabetes Drugs And Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Oman Diabetes Drugs And Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030. Read More

Oman Diabetes Drugs And Devices Market Share

Statistics for the 2023 & 2024 Oman Diabetes Drugs And Devices market share, created by Mordor Intelligence™ Industry Reports. Oman Diabetes Drugs And Devices share report includes a market forecast to 2030 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Oman Diabetes Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

About This Report
- Market Snapshot
- Market Overview
- Key Market Trends
- Competitive Landscape
- Major Players
- Recent Developments
Table of Contents
Scope of the Report
Frequently Asked Questions

Oman Diabetes Drugs and Devices Industry Overview

In order to survive in the market, manufacturers have constantly innovated. Large companies like Abbott and Medtronic have made numerous mergers, acquisitions and partnerships to gain market dominance while adhering to organic growth strategies. Manufacturers of insulin dosing devices spend a lot of money on R&D of the drugs and devices.